Carolina Wealth Advisors, LLC Bristol Myers Squibb CO Transaction History

Carolina Wealth Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 18, 2022	SELL	$61.48 - $73.72 $24,592 - $29,488	-400 Closed	0 $0
Q4 2021 Jan 24, 2022	SELL	$53.63 - $62.52 $418,474 - $487,843	-7,803 Reduced 95.12%	400 $25,000
Q3 2021 Oct 22, 2021	SELL	$59.17 - $69.31 $17,100 - $20,030	-289 Reduced 3.4%	8,203 $485,000
Q2 2021 Jul 22, 2021	SELL	$61.91 - $67.42 $11,824 - $12,877	-191 Reduced 2.2%	8,492 $567,000
Q1 2021 Apr 09, 2021	SELL	$59.34 - $66.74 $527,176 - $592,918	-8,884 Reduced 50.57%	8,683 $548,000
Q4 2020 Jan 29, 2021	SELL	$57.74 - $65.43 $13,511 - $15,310	-234 Reduced 1.31%	17,567 $1.09 Million
Q3 2020 Oct 19, 2020	BUY	$57.43 - $63.64 $77,932 - $86,359	1,357 Added 8.25%	17,801 $1.07 Million
Q2 2020 Jul 31, 2020	BUY	$54.82 - $64.09 $78,721 - $92,033	1,436 Added 9.57%	16,444 $967,000
Q1 2020 Apr 09, 2020	BUY	$46.4 - $67.43 $271,672 - $394,802	5,855 Added 63.97%	15,008 $837,000
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $450,419 - $587,531	9,153 New	9,153 $588,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Carolina Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Carolina Wealth Advisors, LLC with notifications on news.